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Abstract Acinetobacter is involved in a variety of infectious diseases primarily associated with
healthcare. Recently there has been increasing evidence of the important role these pathogens
play in community-acquired infections.
We report on the case of a previously healthy child, aged 28 months, admitted for fever,
cough and pain on the left side of the chest, which on radiographic examination corresponded
to a lower lobe necrotising pneumonia. After detailed diagnostic work-up, community acquired
Acinetobacter lwofﬁi pneumonia was diagnosed.
The child had frequently shared respiratory equipment with elderly relatives with chronic
obstructive pulmonary disease. As there were no other apparent risk factors, it could be assumed
that the sharing of the equipment was the source of infection.
The authors wish to draw attention to this possibility that a necrotising community-acquired
pneumonia due to Acinetobacter lwofﬁi can occur in a previously healthy child and to the
dangers of inappropriate use and poor sterilisation of nebulisers. This case is a warning of the
dangers that these bacteria may pose in the future in a community setting.
© 2011 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L. All rights
reserved.
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Pneumonia adquirida na comunidade por Acinetobacter numa crianc¸a saudável
Resumo O género Acinetobacter tem sido implicado numa grande variedade de doenc¸as infe-
ciosas, em particular, nas infec¸ões associadas aos cuidados de saúde. Atualmente há evidência
a enfatizar o papel deste microrganismo nas infec¸ões adquiridas na comunidade.
É relatado o caso de uma crianc¸a previamente saudável, de 28 meses de idade, internada
por febre associada a tosse e dor localizada no hemitórax esquerdo e cuja radiograﬁa torácicaCrianc¸a
revelou pneumonia necrotisante do lobo inferior. A investigac¸ão diagnóstica efetuada permitiu
o diagnóstico de Pneumonia adquirida na comunidade a Acinetobacter lwofﬁi.
A crianc¸a partilhava frequentemente o seu equipamento respiratório com familiares idosos
com doenc¸a pulmonar crónica obstrutiva. Dado não terem sido apurados outros fatores de risco,
considera-se que a partilha do equipamento poderá ter sido o foco infecioso.
 Please cite this article as: Moreira Silva G, et al. Pneumonia adquirida na comunidade numa crianc¸a saudável por acinetobacter. Rev
ort Pneumol. 2011. doi:10.1016/j.rppneu.2011.07.006.
∗ Corresponding author.
E-mail address: giselavaqueiro@yahoo.com.br (G. Moreira Silva).
173-5115/$ – see front matter © 2011 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L. All rights reserved.
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Os autores pretendem alertar para a possibilidade de Pneumonia adquirida na comunidade
por Acinetobacter lwofﬁi, numa crianc¸a previamente saudável, relacionada com o mau uso
e limpeza dos nebulizadores. Este caso realc¸a o papel emergente desta bactéria, mesmo no
contexto comunitário.
© 2011 Sociedade Portuguesa de Pneumologia. Publicado por Elsevier España, S.L. Todos os
direitos reservados.
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iIntroduction
The genus Acinetobacter, an aerobic Gram-negative
cocobacilli, was originally identiﬁed during 1930s1 and it is
ubiquitous in the environment (soil, fresh water, vegetables,
animals).1 The seasonal increase is probably due to rising
temperatures in the environment.2
It has also been isolated in food, ventilator equipment,
infusions pumps, sinks, stainless steel trolleys, pillows, mat-
tresses, tap water, bed rails, humidiﬁers, soap dispensers
and others sources.2
As a frequent skin and oropharyngeal commensal,2,3 it is
a well-recognized pathogen causing nosocomial pneumonia,
predominantly found in Intensive Care Units (ICU), immuno-
suppressed patients, parenteral nutrition, broad-spectrum
antimicrobial therapy (long course), invasive procedures
(endotracheal and nasogastric intubation, assisted ventila-
tion) and prolonged venous catheterization.3
It is not normally associated with community-acquired
pneumonia (CAP), in which most of the reported cases
are associated with diminished host defences such as
alcoholism, smoking, renal failure, chronic obstructive
pulmonary disease (CPOD) and diabetes mellitus.3,4 Spo-
radic cases have occurred occasionally in healthy patients
exposed to environmental sources,5 although a natural
reservoir for community-acquired Acinetobacter infection
was not identiﬁed.6
Case report
Female child, 28 months of age, vaccinations up to date
(including four doses of antipneumococcal heptavalent vac-
cine) with a history of recurrent episodes of acute otitis
media and wheezing from the age of seven months. The child
had frequently shared respiratory equipment with elderly
relatives with chronic obstructive pulmonary disease. The
respiratory equipment was used to deal with the child’s
wheezing episodes.
The child was treated by Emergency Department, in
December; she had a fever (39 ◦C), which had been persis-
tent for the previous four days and an occasional emetic
cough and runny nose. Initially diagnosed with acute
media otitis, the patient was treated with clarithromycin
(15mg/kg a day). Three days after her initial visit, she was
admitted due to persistent symptoms and pain on the left
side of her chest. Physical examination recorded a slight pal-
lor, nasal ﬂutter and a decrease in breathing on the left
(especially low down) and discrete pleural rub.
Laboratory tests showed an increased white blood
cells count (WBC) 19.7× 109/L; 73% of polymorfonuclears
a
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rigure 1 Computerized axial tomography to reveal upper and
eft lower lobe pneumonia.
eutrophils (N) and 19.4% of lymphocytes (L) and C-reative
rotein (CRP): 284.4mg/L; thorax X-ray revealed a left
onsolidation occupying left costophrenic angle and thoracic
ltrasound showed a small left pleural effusion. Thoracic
omputed axial tomography (see Fig. 1) showed left pleural
ffusion, alveolar inﬁltration of left upper lobe with cav-
tation areas in its superior and posterior lobe related to
ecrotic process.
The patient was admitted to a tertiary care hospital for
ntravenous antibiotics (Ceftriaxone 75mg/kg a day). Five
ays later, blood culture, taken immediately after hospi-
al admission revealed Acinetobacter lwofﬁi. The antibiotic
egimen was changed to ceftazidime (115mg/kg a day)
nd gentamicin (5mg/kg a day) according to the antibi-
gram. The patient’s condition improved rapidly after
his treatment. Based on this evidence the diagnosis of
ommunity-acquired necrotising pneumonia due to this
gent was made.
The patient completed an 18 days course of intravenous
reatment and was discharged with cotrimoxazole to be
aken for a further seven days.
Laboratory research carried out throughout the hospital
tay included: normal complement factors count, humoral
nd cellular immunological study, negative serologic tests
or human immunodeﬁciency virus type 1 and 2 and for
ycoplasma pneumonia and negative skin tests for Mycobac-
erium tuberculosis.
It was difﬁcult to ﬁnd the source of Acinetobacter lwofﬁi
n the case concerned. In fact a lot of work was done in an
ttempt to isolate possible environmental factors, in partic-
lar tap water. The laboratory analysis of tap water showed
o pathogens. The search for the pathogen in the aerosol
eservoir was not undertaken due to technical problems.
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Two years later with follow-up consultation, the patient
emains well and has not been readmitted to hospital.
iscussion
ver 20 species belonging to the Acinetobacter genus have
een identiﬁed.5 Acinetobacter baumanni is the specie of
reatest clinical importance and is associated with hospital
utbreaks, but other species have been related to human
isease such as Acinetobacter lwofﬁi.1
Acinetobacter has been traditionally classiﬁed as a low
pportunistic pathogen, that typically causes serious infec-
ion in immune-compromised hosts.5,6 It is likely that several
actors may contribute to the transition from colonizer to
nvasive bacteria.
It is involved in a variety of infectious diseases, mainly
osocomial infections and less commonly in community-
cquired infections. Although, community-acquired infec-
ions due to these pathogens are still rarely reported,
cinetobacter has been increasingly recognized as a
athogen associated with high morbidity and mortality
n the community-setting.2 Pneumonia is the most com-
only reported infection. Affected patients typically suffer
rom various comorbidities,2 but there is an emergence of
ommunity-acquired infections even in patients who are not
ritically ill.7 This may be connected either to its powers
f survival or resistance to major groups of antibiotics.3 In
ur case, the patient showed no immunodeﬁciency or risk
actors.
Fulminant course with an acute onset of dyspnea, cough,
leuritic chest pain and fever rapidly progressing to respira-
ory failure and shock, is the most common manifestation3,5
nd distinguishing it from CAP due to other bacteria is quite
ifﬁcult.3,5
Chest X-ray may reveal either lobar consolidation or
ronchopneumonia, but progression to diffuse, bilateral
nvolvement often occurs rapidly.4 Pleural effusion may
ccur in half the cases.4 On rare occasions, an empyema
r an abcess and multiple cavitations will complicate the
nitial infection.4
A deﬁnitive diagnosis is established by the presence of
linical signs compatible with pneumonia, associated with
solation of the agent by bronchoalveolar lavage or pleural
ffusion, lung biopsy or blood culture. Blood culture will
onﬁrm suspected cases, establishing a deﬁnitive diagnosis
f Acinetobacter lwofﬁi pneumonia (AL-ACP). As reported
n some studies, in adults, this is clinically unique, with a
igh prevalence of bacteriemia which is associated with a
igher mortality rate.8The source of infection was not established, although
here were several attempts to isolate and identify possi-
le environmental factors. One striking hypothesis was the
haring of nebulisers between the patient and her elderly
8G. Moreira Silva et al.
elatives. Nebulisers should never be shared by patients
nd when prescribed they should be cleaned and disin-
ected after use according to the manufactures’ and doctor’s
nstructions. In fact, inhalation equipment which has not
een properly disinfected between therapy sessions with
ifferent patients has been reported as producing serious
utbreaks of infections, as it is a source of bacterial tract
olonization and infection. As there was no other obvious
isk factor present in this case the sharing of the equipment
as the likely source of infection.
Resistance to several antibiotics hindered therapeutic
anagement. It is already known to be resistant to ampi-
illin, carbenicillin, cefotaxime and chloranphenicol and its
esistance to aminoglycoside is increasing.4 According to
he 2005 guidelines of the American Thoracic Society and
nfectious Disease, empirical therapy should consist of a
seudomonal cephalosporin or piperacillin/tazobactam in
ombination with an aminoglycoside.2 The deﬁnitive treat-
ent should be based on susceptibility results6 and should
ontinue for 3 weeks.4
Early recognition and appropriate antibiotic therapy
ased on culture and susceptibility data are necessary to
void poor outcomes and prevent increasing resistance.7
onclusions
he authors wish to warn of the possibility of a necrotising
ommunity-acquired pneumonia caused by Acinetobacter
wofﬁi in a previous healthy child due to the inappropriate
se and poor sterilisation of nebulisers.
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